Protagenic therapeutics to host webinar with dr. maurizio fava for its lead molecule pt00114 on tuesday, july 13th at 10:00 am et

New york, july 06, 2021 (globe newswire) -- protagenic therapeutics, inc. (nasdaq: ptix) a biopharmaceutical company focused on developing therapies to treat stress-related neurologic disorders, today announced that it will host a key opinion leader (kol) webinar focused on pt00114 for the regulation of stress in patients with depression, ptsd, anxiety and addiction on tuesday, july 13 at 10:00am et.
PTIX Ratings Summary
PTIX Quant Ranking